(Q40912737)

24 September 2017

1 reference

title

A risk-benefit assessment of tamoxifen therapy (English)

1 reference

24 September 2017

1 reference

2

V C Jordan

1 reference

24 September 2017

W H Catherino

1

1 reference

24 September 2017

publication date

1 May 1993

1 reference

24 September 2017

1 reference

24 September 2017

volume

8

1 reference

24 September 2017

issue

5

1 reference

24 September 2017

page(s)

381-397

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199308050-00005

24 September 2017

exact match

0 references

cites work

Tamoxifen-associated hepatocellular damage and agranulocytosis

1 reference

12 December 2020

Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines.

1 reference

12 December 2020

The pharmacology and clinical uses of tamoxifen

1 reference

12 December 2020

Tamoxifen and arterial thrombosis

1 reference

12 December 2020

Comparison between tamoxifen and clomiphene therapy in women with anovulation

1 reference

12 December 2020

Tamoxifen treatment of metastatic breast cancer and antithrombin III levels

1 reference

12 December 2020

Effects of anti-estrogens on bone in castrated and intact female rats

1 reference

12 December 2020

Antitumor actions of toremifene in the 7,12-dimethylbenzanthracene (DMBA)-induced rat mammary tumor model

1 reference

12 December 2020

Determination and pharmacology of a new hydroxylated metabolite of tamoxifen observed in patient sera during therapy for advanced breast cancer.

1 reference

12 December 2020

Tamoxifen as risk factor for carcinoma of corpus uteri

1 reference

12 December 2020

Use of medroxyprogesterone acetate to prevent menopausal symptoms

1 reference

12 December 2020

Sex steroid receptor proteins in foetal, adult and malignant human liver tissue

1 reference

12 December 2020

A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer

1 reference

12 December 2020

Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model

1 reference

12 December 2020

Immune-deficient animals to study "hormone-dependent" breast and endometrial cancer

1 reference

12 December 2020

Bilateral primary breast cancer: a prospective study of disease incidence.

1 reference

12 December 2020

Cytochrome P-450-mediated activation and irreversible binding of the antiestrogen tamoxifen to proteins in rat and human liver: possible involvement of flavin-containing monooxygenases in tamoxifen activation

1 reference

12 December 2020

Variant human breast tumor estrogen receptor with constitutive transcriptional activity

1 reference

12 December 2020

The effect of estrogen and tamoxifen on hepatocyte proliferation in vivo and in vitro

1 reference

12 December 2020

Estrogen-like effects of tamoxifen on human endometrial carcinoma transplanted into nude mice

1 reference

12 December 2020

Tamoxifen (antiestrogen) therapy in advanced breast cancer

1 reference

12 December 2020

Effects of the antiestrogens tamoxifen and clomiphene on bone resorption in vitro

1 reference

12 December 2020

Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma

1 reference

12 December 2020

Potential role of tamoxifen in prevention of breast cancer

1 reference

12 December 2020

Thrombophlebitis and cancer

1 reference

12 December 2020

Tamoxifen as a risk factor for endometrial cancer

1 reference

12 December 2020

Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer.

1 reference

12 December 2020

Tamoxifen Treatment of Advanced Breast Carcinoma

1 reference

12 December 2020

Development of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture

1 reference

12 December 2020

Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer

1 reference

12 December 2020

Estradiol-stimulated growth of MCF-7 tumors implanted in athymic mice: a model to study the tumoristatic action of tamoxifen

1 reference

12 December 2020

Therapeutic effect of tamoxifen alone versus tamoxifen in combination wtih gestagen and oestrogen in advanced breast cancer.

1 reference

12 December 2020

Tamoxifen and liver damage

1 reference

12 December 2020

Long-term adjuvant tamoxifen in early breast cancer: effect on bone mineral density in postmenopausal women

1 reference

12 December 2020

Antithrombin III Level, Fibrinogen Level, and Platelet Count Changes With Adjuvant Tamoxifen Therapy

1 reference

12 December 2020

Estrogen receptors in hepatocellular carcinoma

1 reference

12 December 2020

Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice

1 reference

12 December 2020

Retinopathy caused by treatment with tamoxifen in low dosage

1 reference

12 December 2020

Abnormal Reproductive Development in Rats after Neonatally Administered Antiestrogen (Tamoxifen)

1 reference

12 December 2020

Tamoxifen therapy in primary breast cancer: biology, efficacy, and side effects

1 reference

12 December 2020

Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two years

1 reference

12 December 2020

Tamoxifen Therapy in Postmenopausal Advanced Breast Cancer: Efficacy at the Primary Tumor Site in 46 Evaluable Patients

1 reference

12 December 2020

Bone mineral content of women receiving tamoxifen for mastalgia

1 reference

12 December 2020

Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee

1 reference

12 December 2020

The clinical features and natural history of malignant liver tumours

1 reference

12 December 2020

Effect of steroidal and nonsteroidal antiestrogens on the growth of a tamoxifen-stimulated human endometrial carcinoma (EnCa101) in athymic mice

1 reference

12 December 2020

Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels

1 reference

12 December 2020

Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats

1 reference

12 December 2020

Tamoxifen use, oestrogen binding and serum lipids in postmenopausal women with breast cancer

1 reference

12 December 2020

Ocular assessment of patients treated with tamoxifen

1 reference

12 December 2020

Tamoxifen retinopathy

1 reference

12 December 2020

Identification of estrogenic tamoxifen metabolite(s) in tamoxifen-resistant human breast tumors

1 reference

12 December 2020

Psychological distress after initial treatment of breast cancer. Assessment of potential risk factors

1 reference

12 December 2020

Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptor

1 reference

12 December 2020

Hemostatic abnormalities associated with malignant diseases

1 reference

12 December 2020

New regimen of combination hormone therapy (ME-TA-MAP) in the treatment of advanced breast cancer. A pilot study

1 reference

12 December 2020

Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts

1 reference

12 December 2020

Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programme

1 reference

12 December 2020

Synthetic oestrogens in mammary cancer

1 reference

12 December 2020

Bilateral optic neuritis evolved during tamoxifen treatment

1 reference

12 December 2020

Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen

1 reference

12 December 2020

Primary hepatocellular carcinoma. Present state of the disease and prospects for the future

1 reference

12 December 2020

Hormone receptor assays: clinical usefulness in the management of carcinoma of the breast

1 reference

12 December 2020

Hepatomas: hormone receptors and therapy

1 reference

12 December 2020

A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity

1 reference

12 December 2020

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

A controlled study of the ocular effects of tamoxifen in conventional dosage in the treatment of breast carcinoma

1 reference

12 December 2020

Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients

1 reference

12 December 2020

The effect of tamoxifen on bone mineral content in premenopausal women with breast cancer

1 reference

12 December 2020

Reversible control of oestradiol-stimulated growth of MCF-7 tumours by tamoxifen in the athymic mouse

1 reference

12 December 2020

Tamoxifen retinopathy. A clinicopathologic report

1 reference

12 December 2020

Endometrial carcinoma in five patients with breast cancer on tamoxifen therapy

1 reference

12 December 2020

Oral medroxyprogesterone in the treatment of postmenopausal symptoms

1 reference

12 December 2020

A non-steroidal estrogen antiagonist 1-(p-2-diethylaminoethoxyphenyl)-1-phenyl-2-p-methoxyphenyl ethanol

1 reference

12 December 2020

Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells

1 reference

12 December 2020

Teratogenic effects of clomiphene, tamoxifen, and diethylstilbestrol on the developing human female genital tract

1 reference

12 December 2020

Tamoxifen and progesterone effects in target tissues during the perinatal period

1 reference

12 December 2020

Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumors from breast cancer patients

1 reference

12 December 2020

Endocrine pharmacology of antiestrogens as antitumor agents

1 reference

12 December 2020

Oestrogen-responsive human breast cancer in long term tissue culture

1 reference

12 December 2020

The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor beta

1 reference

12 December 2020

Estrogen responsive proliferation of clonal human breast carcinoma cells in athymic mice

1 reference

12 December 2020

Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitro.

1 reference

12 December 2020

Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens

1 reference

12 December 2020

Effects of tamoxifen on cardiovascular risk factors in postmenopausal women

1 reference

12 December 2020

Characterization of estrogen receptor variant mRNAs from human breast cancers

1 reference

12 December 2020

Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men

1 reference

12 December 2020

Mammary cancer induced by a single feeding of polymucular hydrocarbons, and its suppression.

1 reference

12 December 2020

The induction of ovulation by tamoxifen

1 reference

12 December 2020

Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance

1 reference

12 December 2020

Localization of basic fibroblast growth factor and transforming growth factor beta 1 in the human mammary gland

1 reference

12 December 2020

Growth factors, endocrine aspects and hormonal treatment in hepatocellular carcinoma--an overview

1 reference

12 December 2020

Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Analysis at six years by Nolvadex Adjuvant Trial Organisation

1 reference

12 December 2020

Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice

1 reference

12 December 2020

Tamoxifen retinopathy at low dosage

1 reference

12 December 2020

Estrogen and androgen receptors in liver: their role in liver disease and regeneration

1 reference

12 December 2020

Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications

1 reference

12 December 2020

Venous thrombosis as a side effect of tamoxifen treatment

1 reference

12 December 2020

Combination therapy with progestins and tamoxifen in advanced breast cancer: A preliminary report

1 reference

12 December 2020

Effects of ethinyl estradiol and tamoxifen on liver DNA turnover and new synthesis and appearance of gamma glutamyl transpeptidase-positive foci in female rats

1 reference

12 December 2020

DES versus tamoxifen in advanced breast cancer

1 reference

12 December 2020

Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions

1 reference

12 December 2020

[Hepatocellular carcinoma (HCC): the long-term response to tamoxifen. A clinical case report and review of the literature]

1 reference

12 December 2020

Role and mechanism of action of tamoxifen in premenopausal women with metastatic breast carcinoma

1 reference

12 December 2020

Tamoxifen and contralateral breast cancer

1 reference

12 December 2020

Effects of tamoxifen treatment on plasma lipids and lipoprotein lipid composition

1 reference

12 December 2020

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

1 reference

12 December 2020

Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancer. CRC Adjuvant Breast Trial Working Party

1 reference

12 December 2020

Oestrogen-receptor interaction in target tissues

1 reference

12 December 2020

Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study

1 reference

12 December 2020

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

1 reference

12 December 2020

Variant estrogen receptor mRNA species detected in human breast cancer biopsy samples.

1 reference

12 December 2020

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

1 reference

12 December 2020

Induction of covalent DNA adducts in rodents by tamoxifen.

1 reference

12 December 2020

Organic delusional syndrome associated with tamoxifen treatment

1 reference

12 December 2020

Anti-oestrogen therapy of advanced mammary carcinoma

1 reference

12 December 2020

Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse

1 reference

12 December 2020

Long-term adjuvant tamoxifen therapy for breast cancer

1 reference

12 December 2020

Tamoxifen: an overview of recent studies in the field of oncology

1 reference

12 December 2020

A case of peliosis hepatis in association with tamoxifen therapy

1 reference

12 December 2020

Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group

1 reference

12 December 2020

Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen.

1 reference

12 December 2020

Ocular toxicity of tamoxifen

1 reference

12 December 2020

Antagonism of chemotherapy-induced cytotoxicity for human breast cancer cells by antiestrogens

1 reference

12 December 2020

A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474

1 reference

12 December 2020

Reversible central nervous system dysfunction due to tamoxifen in a patient with breast cancer

1 reference

12 December 2020

Estrogens and endometrial cancer. Responses to arguments and current status of an epidemiologic controversy

1 reference

12 December 2020

N-nitrosomethylurea as mammary gland carcinogen in rats

1 reference

12 December 2020

Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifen

1 reference

12 December 2020

Tamoxifen in advanced breast cancer

1 reference

12 December 2020

A new derivative of triphenylethylene: effect on implantation and mode of action in rats.

1 reference

12 December 2020

Tamoxifen and thromboembolism

1 reference

12 December 2020

Tumor promotion as a target for estrogen/antiestrogen effects in rat hepatocarcinogenesis

1 reference

12 December 2020

Tamoxifen retinopathy.

1 reference

12 December 2020

Tamoxifen, serum lipoproteins and cardiovascular risk

1 reference

12 December 2020

Occurrence of genital tract abnormalities and bladder hernia in female mice exposed neonatally to tamoxifen

1 reference

12 December 2020

Research directions in osteoporosis

1 reference

12 December 2020

T47DCO cells, genetically unstable and containing estrogen receptor mutations, are a model for the progression of breast cancers to hormone resistance.

1 reference

12 December 2020

A phase II trial of tamoxifen in hepatocellular carcinoma

1 reference

12 December 2020

Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel

1 reference

12 December 2020

Tamoxifen and thrombosis

1 reference

12 December 2020

Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment

1 reference

12 December 2020

1 reference

12 December 2020

Biochemical pharmacology of antiestrogen action

1 reference

12 December 2020

Controlled clinical trial of doxorubicin and tamoxifen versus doxorubicin alone in hepatocellular carcinoma

1 reference

12 December 2020

A woman's heart. An update of coronary artery disease risk in women

1 reference

12 December 2020

Effect of tamoxifen on oestrogen binding, lipid and lipoprotein concentrations and blood clotting parameters in premenopausal women with breast pain

1 reference

12 December 2020

Four case reports presenting new acquisitions on the association between breast and endometrial carcinoma

1 reference

12 December 2020

Cholesterol and lipids in the risk of coronary artery disease--the Framingham Heart Study

1 reference

12 December 2020

10.2165/00002018-199308050-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

24 September 2017

1012292226

0 references

1 reference